EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›YHNA

YHNA

YHN Acquisition I Ltd

Next earnings ≈ Aug 10, 2026 · est. from filing cadence

Avoid
$10.86
▲ 0.00%
$10.86▲ +5.13%
over 1Y
L $10.33H $10.99
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.0%
1W+0.0%
1M+0.0%
3M+1.2%
YTD+2.4%
1Y+5.1%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
B-
Valuation
Fair value
Filings
Flagged
Avoid
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••

Pre-deal Hong Kong blank-check shell trading ~8% over its ~$10 trust floor — you're paying a premium for a lottery ticket.

Price $10.86 · current

YHNA is not an operating business — it is a British Virgin Islands special-purpose acquisition company that IPO'd on 2024-09-19, raising $60M (6M units at $10) plus a $2.5M sponsor private placement, with $60.3M deposited in trust. The MD&A is explicit: 'we will not be generating any operating revenues until the closing and completion of our initial business combination.' The entire $1.33M FY2025 'net income' is just interest and dividend income on the trust account net of formation/operating costs — not earnings from any business. So the fundamentals lens tells you nothing about business quality; there is no business yet.

The balance sheet is a classic SPAC optical illusion, not distress: negative stockholders' equity of -$2.19M and a -1.07x liabilities/equity ratio arise because the redeemable public shares sit in temporary equity, outside permanent equity. But two hard numbers are real and unfavorable. First, total assets collapsed 56% YoY to $27.2M and shares outstanding fell 44.7% to 4.29M — consistent with heavy shareholder redemptions that have already gutted the trust and the deal's buying power. Second, operating cash flow swung to -$1.11M (from positive), cash outside trust is down to $141K, and current liabilities exploded 576% to $846K against just $153K of current assets — the shell is burning working capital ($10K/month to the sponsor plus public-company costs) with almost no unrestricted cash to fund a search.

Financials · annual, by fiscal year

Line itemFY24FY25
Revenue——
Gross profit——
Operating income——
Net income$503K$1.33M
Diluted EPS——
Net margin——

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$46.4M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield2.8%
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt—
Net cash$141K
Piotroski F-Score3/6

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY-44.7%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has skewed negative — read the flagged items.
  1. 8-K Other event2026-06-22

    Other-event update (likely deal/listing status); no changed terms for holders

  2. 8-K Delisting notice2026-06-11

    Second Nasdaq deficiency/delisting notice — listing increasingly at risk

  3. 10-Q Quarterly report2026-05-14

    Q1'26: still pre-deal; trust shrunk post-redemptions, cash very thin

  4. 8-K Delisting notice2026-04-20

    Received Nasdaq listing-rule deficiency notice — delisting risk

  5. 10-K Annual report2026-03-31

    FY25 net income $1.33M on trust interest; equity negative, cash only $141K

  6. 8-K Other event2026-03-23

    Other-event disclosure (likely deal/extension update); terms unchanged

  7. 8-K Material agreement2025-12-17

    Entered a material definitive agreement (likely business-combination deal)

  8. 8-K Other event2025-12-16

    Other event — likely extension/redemption results as deadline neared

  9. DEF 14A Proxy statement2025-11-14

    Q3'25: no target yet; trust intact, routine SPAC results

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-172026-06-22open ↗8-KPeriod ending 2026-06-102026-06-11open ↗10-QPeriod ending 2026-03-312026-05-14open ↗8-KPeriod ending 2026-04-172026-04-20open ↗SCHEDULE 13G/AFiling2026-04-07open ↗10-KPeriod ending 2025-12-312026-03-31open ↗4/APeriod ending 2025-08-012026-03-31open ↗8-KPeriod ending 2026-03-192026-03-23open ↗SCHEDULE 13G/AFiling2026-02-13open ↗SCHEDULE 13G/AFiling2026-02-12open ↗SCHEDULE 13G/AFiling2026-02-11open ↗SCHEDULE 13G/AFiling2026-02-02open ↗

Quality score

B-
ValueGrowthProfitHealthMom.
Value—
GrowthA+
Profitability—
Financial healthF
MomentumB+
  • ✓Profitable (positive net income)
  • ✓Liabilities below 2× equity
10.3452-week10.99
Revenue
—
Net margin
—
ROE
—
P/E
—

SEC fundamentals · FY 2025

'24'25

■ revenue · ■ net income, by fiscal year

Net income$1.33M+163.6%
Cash & equivalents$141K-79.0%
Total assets$27.2M-56.0%
Total liabilities$2.35M+44.3%
Stockholders' equity-$2.19M-142.1%
L/E: -1.07x

Frequently asked

Is YHN Acquisition I Ltd (YHNA) a buy?
YHNA currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Pre-deal Hong Kong blank-check shell trading ~8% over its ~$10 trust floor — you're paying a premium for a lottery ticket.
What is YHN Acquisition I Ltd's quality score?
YHNA scores 68.62941340005557/100 (grade B-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0002020987, latest 10-Q filed 2026-05-14) · EODHD · Proprietary analysis · as of 7/4/2026, 3:40:39 AM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2025-08-01
Tominaga Satoshi
Insider
Sell15.0K @ $214.29$3.21M
2024-09-19
YHN Partners I Ltd
10% owner
Buy250K @ $10.00$2.50M

Recent news

market news →
YHN Acquisition I appoints Christy Poon Man Ka as CEO following Satoshi Tominaga’s resignationBullish
investing.com· 2025-07-14

Vs tracked universe

compare →

1195 tracked peers · median

EDGAR Score69 vs 67
Revenue growth— vs 7.5%
Net margin— vs 10.0%
Return on equity— vs 12.0%
P/E— vs 26.2